Alpha Tau Medical Ltd

NASDAQ DRTS

Download Data

Alpha Tau Medical Ltd Current Ratio 1 year YoY Change (%) for the quarter ending March 31, 2024: -47.53%

Alpha Tau Medical Ltd Current Ratio 1 year YoY Change (%) is -47.53% for the quarter ending March 31, 2024, a -288.76% change year over year. The current ratio assesses a company's short-term liquidity and its ability to cover its current liabilities with its current assets. It is calculated by dividing current assets by current liabilities. This ratio indicates the number of times a company's current assets can cover its current liabilities. A higher current ratio suggests better liquidity and a stronger ability to meet short-term obligations. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
  • Alpha Tau Medical Ltd Current Ratio for the quarter ending March 31, 2023 was 22.11, a 25.18% change year over year.
  • Alpha Tau Medical Ltd Current Ratio for the quarter ending March 31, 2022 was 17.66, a 138.36% change year over year.
  • Alpha Tau Medical Ltd Current Ratio for the quarter ending March 31, 2021 was 7.41, a -67.40% change year over year.
  • Alpha Tau Medical Ltd Current Ratio for the quarter ending March 31, 2020 was 22.73, a 2.79% change year over year.
NASDAQ: DRTS

Alpha Tau Medical Ltd

CEO Mr. Uzi Sofer
IPO Date March 8, 2021
Location Israel
Headquarters 5 Kiryat Hamada Street, Jerusalem, Israel, 9777605
Employees 121
Sector Healthcare
Industry Biotechnology
Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Similar companies

TNYA

Tenaya Therapeutics Inc

NA

NA

MNOV

MediciNova Inc

NA

NA

ELYM

Eliem Therapeutics Inc

NA

NA

CYT

Cyteir Therapeutics Inc

NA

NA

HCWB

HCW Biologics Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email